There has been an increase in the use of medical cannabis to treat drug-resistant epilepsy in children. In a recent study, researchers interviewed parents to understand the barriers that they faced while trying to access medical cannabis for their children. While many parents viewed cannabis as an acceptable treatment for epilepsy following the failure of regular anti-epileptic drugs, they encountered resistance in obtaining medical authorization for its use in their child’s treatment. Some reported spending up to $2 000 per month on medical cannabis, but they were frustrated that it was not eligible for reimbursement through insurance programs.
